Pyoderma gangrenosum was first described as an extraintestinal manifestation of inflammatory bowel disease (IBD) by Brunsting and colleagues in 1930. 1 They described painful enlarging necrotic ulcers ...

1 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China 2 College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States Pyoderma ...

Pyoderma gangrenosum is a rare but serious ulcerating skin disease, the treatment of which is mostly empirical. Pyoderma can present to a variety of health professionals and several variants exist ...

Pyoderma gangrenosum is a chronic ulcerating skin disorder of unknown cause that develops in approximately 2% of patients with inflammatory bowel disease (IBD). Several case reports have indicated ...

3 Department of Medicine/Wound Care, Jersey Shore University Medical Center, Neptune, New Jersey, USA Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that may be difficult to diagnose and ...

Very rare, but not entirely mysterious. Pyoderma gangrenosum, the skin disease that afflicted a female patient in Pangasinan, is so rare that a dermatologist from a reputable Philippine hospital had ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

Pyoderma gangrenosum is a diagnosis of exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complications in patients who have other causes of severe cutaneous ulceration.

Familial Mediterranean fever (FMF) is an autoinflammatory disorder characterised by recurrent fever attacks and serositis. Chronic inflammatory seronegative arthropathy affects the spine and ...

JENA, Germany, March 08, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, ...